WHAT'S KNOWN ON THIS SUBJECT: Preterm infants can be successfully resuscitated with ,100% oxygen (O 2 ); however, initiation with room air remains controversial. Current Neonatal Resuscitation Program (NRP) guidelines suggest using air or blended O 2 to titrate O 2 to meet target preductal saturation goals.
WHAT THIS STUDY ADDS: This is the first trial to compare a limited O 2 strategy to target NRP-recommended transitional goal saturations versus a high O 2 strategy in preterm infants. The limited O 2 strategy decreased integrated excess oxygen and oxidative stress and improved respiratory outcomes. abstract OBJECTIVE: To determine whether a limited oxygen strategy (LOX) versus a high oxygen strategy (HOX) during delivery room resuscitation decreases oxidative stress in preterm neonates.
METHODS:
A randomized trial of neonates of 24 to 34 weeks' gestational age (GA) who received resuscitation was performed. LOX neonates received room air as the initial resuscitation gas, and fraction of inspired oxygen (FIO 2 ) was adjusted by 10% every 30 seconds to achieve target preductal oxygen saturations (SpO 2 ) as described by the 2010 Neonatal Resuscitation Program guidelines. HOX neonates received 100% O 2 as initial resuscitation gas, and FIO 2 was adjusted by 10% to keep preductal SpO 2 at 85% to 94%. Total hydroperoxide (TH), biological antioxidant potential (BAP), and the oxidative balance ratio (BAP/TH) were analyzed in cord blood and the first hour of life. Secondary outcomes included delivery room interventions, respiratory support on NICU admission, and short-term morbidities.
RESULTS: Forty-four LOX (GA: 30 6 3 weeks; birth weight: 1678 6 634 g) and 44 HOX (GA: 30 6 3 weeks; birth weight: 1463 6 606 g) neonates were included. LOX decreased integrated excess oxygen (+FIO 2 3 time [min]) in the delivery room compared with HOX (401 6 151 vs 662 6 249; P , .01). At 1 hour of life, BAP/TH was 60% higher for LOX versus HOX neonates (13 [9] [10] [11] [12] [13] [14] [15] [16] vs 8 [6] [7] [8] [9] ) mM/U.CARR, P , .01). LOX decreased ventilator days (3 [0-64] vs 8 [0-96]; P , .05) and reduced the incidence of bronchopulmonary dysplasia (7% vs 25%; P , .05).
CONCLUSIONS: LOX is feasible and results in less oxygen exposure, lower oxidative stress, and decreased respiratory morbidities and thus is a reasonable alternative for resuscitation of preterm neonates in the delivery room. Pediatrics 2013;132:e1488-e1496 
Subsequent NICU Management
After NICU admission, all care decisions (including ventilator management) were at the discretion of the attending neonatologist. Target SpO 2 was 88% to 94% throughout the NICU stay per unit policy. Infants with an O 2 requirement at 36 weeks' corrected GA underwent an O 2 challenge test to define BPD. 33 
Data Collection
HR and SpO 2 were downloaded per pulse oximeter manufacturer instructions. Resuscitation interventions and physiologic responses were recorded at 30-second intervals by the OB circulating nurse per routine practice. Cases were reviewed continuously for adherence to NRP and study protocols.
Sample Collection and Analysis
One mL of umbilical cord blood and 0.25 mL of arterial blood were collected without anticoagulant on NICU admission. Serum was separated immediately by using centrifugation and stored at -80°C. 
RESULTS
Eligible neonates, comprising those enrolled and randomly assigned to LOX (n = 44) and HOX (n = 44), are shown in Fig 1. Fifteen neonates ,28 weeks' GA and 29 neonates 29 to 34 weeks' GA were included in each arm. Eleven pairs of twins were included. One pair of monochorionic diamniotic twins were assigned randomly to HOX and 2 pairs of monochorionic diamniotic twins were assigned to LOX. For the remaining 8 pairs, each twin was randomly assigned to different groups. In 1 instance, only 1 twin required resuscitation and was enrolled. LOX and HOX neonates had similar maternal and baseline neonatal characteristics except that breech presentation was higher for HOX neonates (Table 2) .
DR Resuscitation Interventions
As determined by the study protocol, the initial FIO 2 was different for LOX and HOX neonates (Table 3) . Use and maximum level of CPAP, need for PPV, maximum peak inspiratory pressure, and rates of intubation were similar. No neonate required chest compression When change from baseline (Δ) was analyzed, ΔTH was lower and Δoxida-tive balance ratio was higher for LOX infants, with no difference in ΔBAP (Fig 4) .
Respiratory and Other Short-Term NICU Morbidities
Respiratory and other short-term morbidities are shown in Table 4 . There were no differences in the incidence of 30, 31, 42 The optimal SpO 2 percentile for goal saturations during preterm transition is unknown, but $10th percentile is considered normal for parameters such as birth weight. Although in the first 10 minutes of life, the majority of LOX neonates had an SpO 2 above the 10th percentile on the Dawson curves, more LOX infants had an SpO 2 below the 10th percentile compared with HOX. 28 Goos et al recently reported retrospectively that preterm neonates initially resuscitated with 30% O 2 and adjusted to meet NRP goal saturations also resulted in some with SpO 2 below the 10th percentile of the Dawson curves. 28, 44 The significance of this observation is speculative because the effect of brief DR LOX on long-term neurodevelopmental outcome remains unknown. 42 Studies comparing different starting concentrations of O 2 to achieve target goal saturations and, more importantly, effects on both short-and long-term clinical outcomes are warranted; however, based on published studies so far, it seems unlikely that 21% vs 30% O 2 would result in significant differences. 8, 22, 23, [42] [43] [44] [45] To optimize balance between excessive O 2 and hypoxia, future studies comparing different target SpO 2 ranges should be considered. 27, 46 We speculate that various strategies which improve ventilation and establishes functional residual capacity early may further reduce the need for supplemental oxygen. 47, 48 The decrease in ventilator days, rescue HFOV, and BPD in LOX neonates is interesting; however, our study was not powered for secondary outcomes. 4, 12, 50, 51 Infants with BPD exposed to higher supplemental O 2 to achieve higher levels of SpO 2 have more persistent lung disease. 4, 12, 52 We speculate that excess O 2 exposure in the first few minutes of life may blunt vascular development in preterm infants. Development of strategies to minimize oxygen exposure to prevent tissue injury must be a priority. 4 
FIGURE 2
A, Median level of O 2 administered per minute of life for the first 10 minutes of life in preterm neonates randomly assigned to the LOX group, in which initial FIO 2 after birth was 21%, or the HOX group, in which initial FIO 2 after birth was 100%. * P , .05. B, Median SpO 2 per minute of life for first 10 minutes of life in the DR in LOX and HOX infants. * P , .05.
FIGURE 3
A, Proportion of neonates with SpO 2 .94% per minute for the first 10 minutes of life in the DR in the LOX and HOX groups. * P , .05. B, Proportion of neonates with SpO 2 ,10th percentile of Dawson curves for the first 10 minutes of life in the DR in the LOX and HOX groups. * P , .05.
A recent meta-analysis comparing lower (21%-50%) versus higher (.50%) O 2 concentrations for DR resuscitation of preterm infants and their effects on morbidity and mortality identified 6 randomized trials. 8, [22] [23] [24] 42, [53] [54] [55] Lower O 2 reduced the risk of death, but this effect disappeared when limited to studies with adequate allocation concealment. 42 The authors stressed the need for larger trials powered to detect important outcomes, including neurodevelopment and mortality.
The current study has several limitations. Although randomized, the trial was not blinded and is at-risk for bias because the resuscitation team was aware of treatment assignments. However, DR interventions were diligently recorded by the OB circulating nurse who was not involved in the trial (as is our standard practice), and systematic errors that might have unduly influenced randomization or outcome were not found. Video recordings or computerized data acquisition systems other than pulse oximetry for continuous physiologic data were not available. The number of neonates recruited to the trial, which was powered for a difference in oxidative stress markers, did not allow for the evaluation of short-term clinical outcomes such as BPD or long-term neurodevelopmental outcomes with sufficient statistical power.
One of the strengths of the study is that it recapitulates the intended real-world DR use of O 2 . Adjusting FIO 2 in response to SpO 2 every 30 seconds is challenging and might interfere with or delay other steps needed to resuscitate a preterm infant. Lack of research personnel assigned to make these changes provided opportunity to study the effect of these complex interactions in a randomized controlled trial setting. We did not have a visual O 2 targeting system such as TOTS [Transitional Oxygen Targeting System] to help keep saturations within target range. 45 Our study is relevant to most resuscitation situations because the majority of the world' s neonates are resuscitated without a visual targeting system. This is the first randomized trial to use current NRPrecommended O 2 saturation targets in preterm infants needing DR resuscitation. Unlike previous trials examining resuscitation of preterm neonates with LOX, our study included all eligible preterm infants due to antenatal waiver of consent, thereby reducing selection bias and increasing the generalizability of the results. 8, [22] [23] [24] 42, 56 Furthermore, the study population was stratified to 24-to 
